Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre-Reference-Cited by-同舟云学术

Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre

Published:2017-01-12 Issue:4 Volume:116 Page:424-431
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Faluyi Olusola O,Connor Joanna L,Chatterjee Madhuchanda,Ikin Carl,Wong Helen,Palmer Daniel H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016406.pdf

Reference19 articles.

1. Amin S, Lucas AL, Frucht H (2013) Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis. Pancreas 42 (2): 249–253.

2. Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS (2007) Validation of the 6th edition AJCC pancreatic cancer staging system: report from the National Cancer Database. Cancer 110 (4): 738–744.

3. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15 (6): 2403–2413.

4. Cancer Research UK (2016) http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer (accessed on 30 April 2016).

5. Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364 (19): 1817–1825.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multivariable analysis to predict variations in hospital mortality using systems-based factors of healthcare delivery to inform improvements to healthcare design within the English NHS;PLOS ONE;2024-07-05

2. Initial treatment is associated with improved survival and end-of-life outcomes for patients with pancreatic cancer: a cohort study;BMC Cancer;2022-12-14

3. Initial Treatment Is Associated With Improved Survival and End- Of-Life Outcomes for Patients With Pancreatic Cancer: A Cohort Study;2022-08-24

4. Use and outcomes of chemotherapy for metastatic pancreatic cancer in Australia;Internal Medicine Journal;2022-01

5. Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer;Cancers;2021-08-19